Radiological clues to the early diagnosis of hypochondroplasia in the neonatal period: Report of two patients
β Scribed by Tomoko Saito; Keisuke Nagasaki; Gen Nishimura; Masaki Takagi; Tomonobu Hasegawa; Makoto Uchiyama
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 587 KB
- Volume
- 158A
- Category
- Article
- ISSN
- 1552-4825
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Hypochondroplasia (HCH) is the mildest phenotype among fibroblast growth factor receptor 3 (FGFR3)βassociated skeletal dysplasias. Affected individuals usually presents with mild short stature in preschool age. It was uncommon that a diagnosis of HCH is made in young affected children. Recently, however, prenatal ultrasound (US) has increased likelihood of detecting in utero mild short limbs. There have been a few reports on the early diagnosis of HCH in the neonatal period preceded by a suspicion of skeletal dysplasia on fetal US. However, the proper diagnosis of HCH is hampered by absence of the radiological criteria relevant to age, particularly those in the neonatal period. We report on the clinical and radiological findings in two HCH children with a FGFR3 mutation. In both children, fetal US showed short femora and relatively increased biparietal diameter (BPD). However, postnatal assessment failed to make a specific diagnosis in the neonatal period. The correct diagnosis of HCH was accomplished by reassessment after exacerbation of postnatal short stature. In retrospective radiological review, the radiological findings relevant to HCH were discernible more easily in the neonatal period than at age of 3 years. Β© 2012 Wiley Periodicals, Inc.
π SIMILAR VOLUMES
Objective. To determine how well the American College of Rheumatology (ACR; formerly, the American Rheumatism Association) 1987 classification criteria for rheumatoid arthritis (RA), when used at study inclusion in a cohort of 270 patients with early (<1 year) arthritis, predicted a diagnosis of RA
## Background: The use of 5-fluorouracil (5-fu) and levamisole in patients with stage iii adenocarcinoma of the colon has now become standard. there have been several reports of a multifocal cerebral demyelination syndrome following 5-fu and levamisole administration. ## Methods: We describe a pa